Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2154-2162

  Lunde, Elin ^a   Western, Karoline H ^a   Rasmussen, Ingunn B ^a   Sandlie, Inger ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TROYBODIES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; INTRACELLULAR TRANSPORT; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; T LYMPHOCYTE;

EID: 0036498877     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2154     Document Type: Article

References (52)

1. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-Ig
2. Targeted antigen presentation using crosslinked antibody heteroaggregates
3. Receptor-mediated B cell antigen processing: Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures
4. Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody
5. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors
6. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules
7. T cell clones specific for IgG2a of the a allotype: Direct evidence for presentation of endogenous antigen
8. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells
9. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule
10. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule
11. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes
12. Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro
13. Recombinant antibodies possessing novel effector functions
14. Antibodies engineered with IgD specificity efficiently deliver integrated T cell epitopes for antigen presentation by B cells
15. + T cells confer idiotypespecific tumor resistance in the absence of antibodies
16. Weak positive selection of transgenic T cell receptor-bearing thymocytes: Importance of major histocompatibility complex class II. T cell receptor and CD4 surface molecule densities
17. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens
18. Modulation of cytokine expression in mouse dendritic cell clones
19. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by ant
20. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas
21. Antigenspecific I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas
22. Influenza virus site recognized by a murine helper T cell specific for HI strains: Localization to a nine amino acid sequence in the hemagglutinin molecule
23. Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells
24. The principle of delivery of T cell epitopes to antigen presenting cells applied to peptides from influenza virus, ovalbumin and hen egg lysozyme: Implications for peptide vaccination
25. A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus
26. Processing of lysozyme by macrophages: Identification of the determinant recognized by two T-cell hybridomas
27. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
28. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells
29. Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells
30. + T cells in vivo
31. + T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells
32. Antigen presentation by resting B cells: Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation
33. Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule
34. Idiotype-specific, major histocompatibility complex restricted T cells are of both Th1 and Th2 type
35. A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones
36. + single positive cells with a class II major histocompatibility complex-restricted receptor
37. Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis
38. Enhanced antigen immunogenicity induced by bispecific antibodies
39. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens
40. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats
41. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes
42. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization
43. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein
44. Dendritic cells and the control of immunity
45. Crystal structure of uncleaved ovalbumin at 1.95 Å resolution
46. Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity
47. Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules
48. Recombinant antibodies as carrier proteins for subunit vaccines: Influence of mode of fusion on protein production and T cell activation
49. Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcγ, receptors
50. Defective antigen processing in GILT-free mice
51. Proteolysis in MHC class II antigen presentation: Who's in charge?
52. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells